Oramed Pharmaceuticals Stock
Oramed Pharmaceuticals gained 0.640% compared to yesterday. The community is currently still undecided about Oramed Pharmaceuticals with 1 Buy predictions and 1 Sell predictions. With a target price of €15.00 there is a hugely positive potential of 90.114% for Oramed Pharmaceuticals compared to the current price of €7.89. Our community identified positive and negative aspects for Oramed Pharmaceuticals stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Oramed Pharmaceuticals stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Oramed Pharmaceuticals in the next few years
Performance of Oramed Pharmaceuticals vs. its peers
|Enlivex Therapeutics Ltd.||-2.470%||-9.274%||-18.919%||-54.315%||-12.621%||-||-|
|Pluristem Therapeutics Inc.||-3.350%||-9.608%||-20.169%||-78.024%||5.573%||-||-|
|Flexion Therapeutics Inc.||-0.620%||0.000%||0.000%||-20.297%||0.000%||-||-|